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while the native tissue was visually and acoustically homogeneous, the
engineered tissue contains structural discontinuities which correlate well
with the acoustic discontinuities.
Fig. 1. Reﬂections from the front and rear faces of native bovine
cartilage (A) or tissue engineered cartilage (B). In contrast to the native
tissue, there are numerous reﬂections in the engineered tissue.
Conclusions: We have previously shown that speed of sound
measurements can be used to estimate actual mechanical properties
of hydrogels and are working to extend these ﬁndings to cartilage.
The present proof of concept work suggests that ultrasound can
also be used to assess, in a non-contact, non-destructive fashion the
internal homogeneity of growing TE cartilage. We thus suggest that
acoustic homogeneity of engineered tissue is a useful predictor of tissue
homogeneity and thus can be used as a further quality control measure.
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Purpose: Research in bone and cartilage engineering for regenerative
medicine approaches has expanded over the last decade; however,
few methods have been clinically translated. Partially because most
engineered constructs lack anatomical and mechanical characteristics
of native tissues, and can be resorbed after implantation. In this study,
we have derived an engineered bone and cartilage construct (EBCC)
that is collagen based; within a novel biomimetic bioreactor. Previous
results from our lab demonstrated collagen 1 and chondroitin sulphate
to be potent inducers for osteogenesis and chondrogenesis respectively.
However, prolonged maintenance cell viability and application of
mechanical stimulants remains a hurdle in static tissue culture setting.
Hence, a novel bioreactor system capable of emulating physiological
environment speciﬁc for bone and cartilage development was designed;
to enhance potential of the EBCC to possess both anatomical and
mechanical resemblance to tissue in physiology.
Methods: A perfusion bioreactor was designed to provide continual
ﬂow of media to the EBCC at constant ﬂow rate. The design allows
alternation of media compositions in real-time, based on the needs
of the EBCC at each stage of differentiation with minimal disruptions.
An isolated polymerized collagen 1 platform was fabricated within
the bioreactor to support embryonic stem cells (ESC) differentiation.
Nutrients and oxygen gradients developed within the bioreactor are
based on the design of bioreactor and seeding density of ESCs. This
gradient is exploited (with media supplementation) to promote both
osteogenesis and chondrogenesis at different parts of the platform;
resulting in EBCC formation. Furthermore, the materials used to assemble
the bioreactor are amenable to direct mechanical stimulation (bending
and compression) and is applied to the developing EBCC to enhance
differentiation.
Results: Cells in EBCC remained viable for at least 45 days post
inoculation, with extensive cellular remodelling observed. A construct
with ﬁrm structural features was developed. Quantitative PCR (qPCR)
analyses demonstrated signiﬁcant decrease in pluripotent marker, OCT-4,
after 30 days, with coinciding increases in osteogenic and chondrogenic
markers.
Conclusions: This novel bioreactor promotes long term cultivation and
differentiation of the EBCC. Using the cast and mould concept, we
had established an EBCC with speciﬁc shape, that retains mechanical
properties after removal from the bioreactor. In future experiments we
will be applying various mechanical stimulants on the EBCC to drive
further maturation and transplant the construct into critical size skeletal
defects. The EBCC principle, once validated in vitro and in vivo holds
promises as an alternative approach for producing custom implants that
can contain both bone and cartilage components.
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Purpose: Mesenchymal stem cells (MSCs) are promising candidates
for cell therapeutic application in osteoarthritis (OA) and rheumatoid
arthritis (RA). The catabolic environment in joints of OA and RA patients
results in progressive joint damage. MSCs can have anti-catabolic or
anti-inﬂammatory effects by secreting anti-inﬂammatory cytokines and
growth factors. In order to become immunosuppressive MSCs need to be
triggered by for instance pro-inﬂammatory cytokines. We hypothesized
that synovial ﬂuids inﬂuences the immunomodulatory effects of MSCs
and investigated this in vitro by analyzing the gene expression of
immunomodulatory factors.
Methods: Human bone marrow derived MSCs were cultured in
monolayer in serum-free medium with 1% ITS with or without 20%
synovial ﬂuid for 48 hours. Synovial ﬂuid of six OA donors, six RA
donors and three healthy donors were used in triplicate cultures. Gene
expression of immunoregulatory cytokines IL-6, HGF, TNFa, TGFb1 and
